Report ID : 1291683 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Artemether Industry is categorized based on Formulation Type (Injectable, Oral, Others) and Application (Malaria Treatment, Combination Therapy, Others) and End-User (Hospitals, Clinics, Home Care, Pharmacies, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Artemether Industry, valued at $1.2 billion in 2023, is anticipated to expand to $2.5 billion by 2033 at a CAGR of 7.8% from 2024 to 2033. This report covers different segments and offers an analysis of the substantial trends and factors affecting the market.
The Artemether market development growth can be traced back to two primary factors: the rising occurrence of malaria globally and the sophistication of healthcare systems. Plasmodium falciparum, the world's deadliest malaria parasite is accessible, and very easy to treat because Artemether derived from artemisinin and is known for its effectiveness. Artemether is a majorly used drug . Its increased demand can be attributed to its effectiveness and safety.
Based on research conducted over the years, there has been increased attention given to improve Artemisinin-based Combination Therapies (ACTs). Such treatments are imperative in areas where malaria is highly prevalent. There have been advanced steps made globally to combat malaria as an effort to improve the overall health of the population. The initiative taken by private pharmaceutical companies in partnership with industry public health have a positive impact for the Artemether industry. Verified Industry Insights is one of the top players in providing detailed insights and analysis of this highly versatile and important industry.
ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2023-2033 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2033 |
HISTORICAL PERIOD | 2023-2024 |
UNIT | VALUE (USD BILLION) |
KEY COMPANIES PROFILED | Sanofi, Novartis, GSK, Mylan, Ipca Laboratories, Zydus Cadila, Alvogen, Lupin Pharmaceuticals, Sandoz, Fresenius Kabi, Hetero Labs |
SEGMENTS COVERED |
By Formulation Type - Injectable, Oral, Others By Application - Malaria Treatment, Combination Therapy, Others By End-User - Hospitals, Clinics, Home Care, Pharmacies, Others By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
The Artemether Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
Verified Industry Insights offers one of the following report customization options to our respectable clients :
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved